POLICY PROPOSAL: INCREASING ACCESS TO MICROFINANCE FOR DISABLED WOMEN IN KENYA
Contributing writer Gabriella Fleischmann proposes possible solutions to discrimination in microfinance in Kenya.
TOMS AND THE FAILINGS OF THE BUY-ONE-GIVE-ONE MODEL
Staff Writer Zaid Mansuri analyzes the effects of the buy-one-give-one business model on target developing regions
VOLUNTOURISM- HOW SUSTAINABLE IS YOUR SERVICE?
Staff Writer Rebecca Chong looks into the idea behind voluntourism--and many of issues that it brings
FOR POWER OR LOVE - TURKISH INVESTMENT IN SOMALIA
Staff Writer Aisha Ali examines Turkey's involvement and relationship in Somalia
FOUR YEARS LATER: EGYPT'S ONGOING FIGHT FOR DEMOCRACY
Contributing writer Jamie Anderson traces the stumbling development of Egypt's democracy since the Arab Spring
THE CUTTING, THE VIRUS, THE FISTULA
Staff Writer Joyce Sunday discusses the genital mutilation of women in African culture.
THE BIZARRE AND DISTURBING TRIAL OF A LIBYAN WAR CRIMINAL
Senior Editor Omkar Mahajan explains the trial of Libyan military leader Abdullah Senussi and why it is so controversial.
Whose Lives Matter?: A Conversation on Police Brutality Across Borders
Carla Diot traces the back and forth between the United States, Russia, Egypt and Iran as they accuse each other of various human rights violations.
INTERNATIONAL RESPONSES TO THE SOUTH SUDAN CONFLICT
Staff Writer Andrew Muse-Fisher discusses the ongoing conflict in South Sudan and various nations' responses to the matter.
MOROCCO: THE JEWEL OF NORTH AFRICA
Contributing Writer Logan Ma discusses the rich history and culture of Morocco.
“THEY SOLD US LIKE ANIMALS”: MODERN SLAVERY IN THE ILLEGAL FISHING TRADE
Staff Writer Rebecca Benest discusses modern-day slavery in the illegal fishing trade.
BIOETHICS IN EBOLA CLINICAL TRIALS
The standard clinical trial process poses some unique ethical dilemmas when time is scarce. Staff Writer Alexandra Reich writes about how these factors are playing out in the 2014 Ebola epidemic.
EBOLA VACCINE DEVELOPMENT PROVOKES STEM CELL CONTROVERSY
The development of a viable Ebola vaccine is something many groups want to see happen as quickly as possible. But for some the lingering controversy over stem cell research raises some concerns. By Staff Writer Jubilee Cheung
EBOLA AND AIDS: A COMPARISON OF CDC AND PUBLIC REACTIONS
How does the CDC's response to the 2014 Ebola epidemic compare to its handling of the 1980 AIDS outbreak? By Staff Writer Alexandra Reich.